HLB SCIENCE Inc. Logo

HLB SCIENCE Inc.

Develops innovative therapeutics and diagnostics for infectious and neurodegenerative diseases.

343090 | KO

Overview

Corporate Details

ISIN(s):
KR7343090007
LEI:
Country:
South Korea
Address:
서울특별시 송파구 법원로 128씨동 1314호, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HLB SCIENCE Inc. is a global biopharmaceutical company dedicated to developing innovative new drugs for infectious and immune-related diseases. The company's core pipeline focuses on critical unmet medical needs, including therapeutics for bacterial sepsis and infections caused by superbacteria. A key candidate, DD-S052P, is a novel antibiotic designed to neutralize both pathogens and the endotoxins they release. In the field of neurodegenerative diseases, HLB SCIENCE is advancing a treatment for Alzheimer's Disease, DD-A279, which modulates LPS and gram-negative bacteria, complemented by the DD-A514 diagnostic kit for early detection. The company leverages its expertise in life science and medicine to contribute to global health through its innovative therapeutic and diagnostic solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 7.2 KB
2025-09-17 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-09-17 00:00
M&A Activity
[첨부추가]주요사항보고서(회사합병결정)
Korean 52.4 KB
2025-06-19 00:00
Regulatory News Service
기업설명회(IR)개최결과
Korean 6.7 KB
2025-05-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 65.1 KB
2025-05-12 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-09 00:00
Capital/Financing Update
전환가액의조정 (제4회차)
Korean 10.1 KB
2025-04-23 00:00
Regulatory News Service
본점소재지변경
Korean 5.0 KB
2025-03-25 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 20.0 KB
2025-03-25 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 16.6 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 9.7 KB
2025-03-17 00:00
Annual Report
사업보고서 (2024.12)
Korean 1022.1 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 103.6 KB
2025-03-06 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 23.8 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 13.2 KB

Automate Your Workflow. Get a real-time feed of all HLB SCIENCE Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB SCIENCE Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB SCIENCE Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany
BIO3
Biotika A.S. Logo
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia
BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland
BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom
BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland
BIOV
Biovica International B Logo
Develops blood tests to monitor the efficacy of solid tumor cancer therapies.
Sweden
BIOVIC
BIOVIE INC. Logo
Develops drug therapies for Alzheimer's, Parkinson's, and advanced liver diseases by targeting inflammation.
United States of America
BIVI
BioXcel Therapeutics, Inc. Logo
AI-driven biopharma developing treatments for neuroscience and immuno-oncology.
United States of America
BTAI
Black Diamond Therapeutics, Inc. Logo
Develops precision oncology drugs targeting mutation families in lung and brain cancers.
United States of America
BDTX
BL Pharmtech Corp. Logo
Manufactures and distributes health foods, supplements, and cosmetics with bio-pharmaceutical R&D.
South Korea
065170

Talk to a Data Expert

Have a question? We'll get back to you promptly.